STERIS - STE Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STE shares.
View STE analyst ratings or view top-rated stocks.

5 Wall Street research analysts have issued 12-month target prices for STERIS's shares. Their STE share price forecasts range from $210.00 to $275.00. On average, they anticipate the company's stock price to reach $242.40 in the next year. This suggests a possible upside of 26.3% from the stock's current price.
View analysts price targets for STE or view top-rated stocks among Wall Street analysts.

STERIS's stock was trading at $243.41 at the start of the year. Since then, STE stock has decreased by 21.2% and is now trading at $191.91.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 14th 2023.
View our STE earnings forecast.

STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, November, 9th. The medical equipment provider reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.98 by $0.01. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.22 billion. STERIS had a negative net margin of 0.17% and a positive trailing twelve-month return on equity of 12.75%. STERIS's revenue was up .3% on a year-over-year basis. During the same period in the previous year, the company posted $1.99 earnings per share.
Read the conference call transcript.

STERIS declared a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Tuesday, November 22nd will be paid a dividend of $0.47 per share on Friday, December 16th. This represents a $1.88 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Monday, November 21st.
Read our dividend analysis for STE.

STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.98%.
Read our dividend analysis for STE.

STERIS issued an update on its FY23 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $8.40 to $8.60 for the period, compared to the consensus estimate of $8.48.

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

STERIS's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.86%), BlackRock Inc. (8.03%), WCM Investment Management LLC (5.79%), Massachusetts Financial Services Co. MA (5.09%), State Street Corp (4.30%) and Price T Rowe Associates Inc. MD (2.26%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends.

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STE stock can currently be purchased for approximately $191.91.

STERIS (NYSE:STE) has a market capitalization of $19.16 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or ($0.11) on an earnings per share basis.

The company employs 16,422 workers across the globe.

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (531) 232-2000, via email at julie_winter@steris.com, or via fax at 440-639-4457.